Large-scale association analyses identify host factors influencing human gut microbiome composition A Kurilshikov, C Medina-Gomez, R Bacigalupe, D Radjabzadeh, J Wang, ... Nature genetics 53 (2), 156-165, 2021 | 1313 | 2021 |
Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition LB Thingholm, MC Rühlemann, M Koch, B Fuqua, G Laucke, R Boehm, ... Cell host & microbe 26 (2), 252-264. e10, 2019 | 420 | 2019 |
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation S Federici, S Kredo-Russo, R Valdés-Mas, D Kviatcovsky, E Weinstock, ... Cell 185 (16), 2879-2898. e24, 2022 | 320 | 2022 |
Archaea are interactive components of complex microbiomes C Moissl-Eichinger, M Pausan, J Taffner, G Berg, C Bang, RA Schmitz Trends in microbiology 26 (1), 70-85, 2018 | 267 | 2018 |
The fecal mycobiome in non-alcoholic fatty liver disease M Demir, S Lang, P Hartmann, Y Duan, A Martin, Y Miyamoto, ... Journal of hepatology 76 (4), 788-799, 2022 | 261* | 2022 |
Metaorganisms in extreme environments: do microbes play a role in organismal adaptation? C Bang, T Dagan, P Deines, N Dubilier, WJ Duschl, S Fraune, ... Zoology 127, 1-19, 2018 | 239 | 2018 |
First insights into the diverse human archaeome: specific detection of archaea in the gastrointestinal tract, lung, and nose and on skin K Koskinen, MR Pausan, AK Perras, M Beck, C Bang, M Mora, ... MBio 8 (6), 10.1128/mbio. 00824-17, 2017 | 216 | 2017 |
The intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cells C Bang, K Weidenbach, T Gutsmann, H Heine, RA Schmitz PloS one 9 (6), e99411, 2014 | 181 | 2014 |
Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome MC Rühlemann, BM Hermes, C Bang, S Doms, L Moitinho-Silva, ... Nature Genetics 53 (2), 147-155, 2021 | 153 | 2021 |
Archaea associated with human surfaces: not to be underestimated C Bang, RA Schmitz FEMS microbiology reviews 39 (5), 631-648, 2015 | 152 | 2015 |
Alterations of the bile microbiome in primary sclerosing cholangitis T Liwinski, R Zenouzi, C John, H Ehlken, MC Rühlemann, C Bang, ... Gut 69 (4), 665-672, 2020 | 136 | 2020 |
Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function F Frost, T Kacprowski, M Rühlemann, M Pietzner, C Bang, A Franke, ... Gut 70 (3), 522-530, 2021 | 133 | 2021 |
A structured weight loss program increases gut microbiota phylogenetic diversity and reduces levels of Collinsella in obese type 2 diabetics: A pilot study F Frost, LJ Storck, T Kacprowski, S Gärtner, M Rühlemann, C Bang, ... PloS one 14 (7), e0219489, 2019 | 128 | 2019 |
Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis M Kummen, LB Thingholm, MC Rühlemann, K Holm, SH Hansen, ... Gastroenterology 160 (5), 1784-1798. e0, 2021 | 101 | 2021 |
Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis M Rühlemann, T Liwinski, FA Heinsen, C Bang, R Zenouzi, M Kummen, ... Alimentary Pharmacology & Therapeutics 50 (5), 580-589, 2019 | 86 | 2019 |
The Human-Associated Archaeon Methanosphaera stadtmanae Is Recognized through Its RNA and Induces TLR8-Dependent NLRP3 Inflammasome Activation T Vierbuchen, C Bang, H Rosigkeit, RA Schmitz, H Heine Frontiers in immunology 8, 1535, 2017 | 85 | 2017 |
The gut microbiome in patients with chronic pancreatitis is characterized by significant dysbiosis and overgrowth by opportunistic pathogens F Frost, FU Weiss, M Sendler, T Kacprowski, M Rühlemann, C Bang, ... Clinical and translational gastroenterology 11 (9), e00232, 2020 | 81 | 2020 |
Dysbiosis in the gut microbiota in patients with inflammatory bowel disease during remission A Pisani, P Rausch, C Bang, S Ellul, T Tabone, C Marantidis Cordina, ... Microbiology spectrum 10 (3), e00616-22, 2022 | 78 | 2022 |
A disease‐specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis T Liwinski, C Casar, MC Ruehlemann, C Bang, M Sebode, S Hohenester, ... Alimentary Pharmacology & Therapeutics 51 (12), 1417-1428, 2020 | 78 | 2020 |
Microbiomarkers in inflammatory bowel diseases: caveats come with caviar F Sommer, MC Rühlemann, C Bang, M Höppner, A Rehman, C Kaleta, ... Gut 66 (10), 1734-1738, 2017 | 77 | 2017 |